Aronora, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis (NCT03963895) | Aronora, Inc. | 2019-07-03 |
| Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis (NCT03612856) | Aronora, Inc. | 2018-10-29 |
| Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects (NCT03453060) | Aronora, Inc. | 2018-05-30 |
Track Aronora, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.